Skip to main content

Growth Hormone Deficiency SkybriGHt

The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care.

Gnanagurudasan Prakasam
Gnanagurudasan Prakasam
Principal investigator
View Profile

Co-investigator

Ulhas Nadgir

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?